Held in one of the world's leading hubs for medical innovation, this annual event will focus on the latest IT advancements that are accelerating biomedical research and drug discovery and development. Sessions will showcase the role of AI, FAIR (findable, accessible, interoperable and reusable) data, digital twins, bioinformatics and other technologies in catalyzing progress. Examples include:

 

• A partnership between Barts Health NHS Trust and Queen Mary University of London, which are investing £600m pounds in a world-leading open-access exascale causal AI computing platform. This will enable a newly detailed understanding of cancer and other diseases.

• MOSAIC, a $50 million initiative to revolutionize cancer research using spatial omics, offering unprecedented information on the structure of tumors. This is a collaboration between Owkin, Nanostring and world-leading research institutions.

• Another collaboration among 250 research institutes in over 23 countries who are integrating their bioinformatics resources under a common European infrastructure called ELIXIR.

"Bio-IT World Europe will give participants an exclusive opportunity to network with the people behind the innovations originating in Europe and the UK. Many speakers have carefully selected this conference as the best venue to present their research," said Cindy Crowninshield, RDN, LDN, Executive Event Director.

 

Senior-level scientists and researchers, IT professionals and executives from organizations across life sciences, including pharmaceutical, biotechnology, health systems, academia, government, and national laboratories, will participate in more than 60 sessions in five tracks--R&D in pharma, AI for Pharma, Storage Infrastructure & Cloud Computing, Data Management, and Bioinformatics.

 

For conference information, and to register (with discounts until 20 October), see bio-itworldeurope.com.